Crossref journal-article
Rockefeller University Press
The Journal of Experimental Medicine (291)
Abstract

Natural killer (NK) cells and interferon (IFN)-γ have been implicated in immune surveillance against tumor development. Here we show that tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) plays a critical role in the NK cell–mediated and IFN-γ–dependent tumor surveillance. Administration of neutralizing monoclonal antibody against TRAIL promoted tumor development in mice subcutaneously inoculated with a chemical carcinogen methylcholanthrene (MCA). This protective effect of TRAIL was at least partly mediated by NK cells and totally dependent on IFN-γ. In the absence of TRAIL, NK cells, or IFN-γ, TRAIL-sensitive sarcomas preferentially emerged in MCA-inoculated mice. Moreover, development of spontaneous tumors in p53+/− mice was also promoted by neutralization of TRAIL. These results indicated a substantial role of TRAIL as an effector molecule that eliminates developing tumors.

Bibliography

Takeda, K., Smyth, M. J., Cretney, E., Hayakawa, Y., Kayagaki, N., Yagita, H., & Okumura, K. (2002). Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development. The Journal of Experimental Medicine, 195(2), 161–169.

Authors 7
  1. Kazuyoshi Takeda (first)
  2. Mark J. Smyth (additional)
  3. Erika Cretney (additional)
  4. Yoshihiro Hayakawa (additional)
  5. Nobuhiko Kayagaki (additional)
  6. Hideo Yagita (additional)
  7. Ko Okumura (additional)
References 39 Referenced 340
  1. 10.1038/86297 / Nat. Immunol. (2001)
  2. 10.1038/319675a0 / Nature. (1986)
  3. 10.1016/S0065-2776(08)60664-1 / Adv. Immunol. (1989)
  4. 10.1093/intimm/13.4.459 / Int. Immunol. (2001)
  5. 10.1084/jem.191.4.661 / J. Exp. Med. (2000)
  6. 10.1002/(SICI)1521-4141(199904)29:04<1390::AID-IMMU1390>3.0.CO;2-C / Eur. J. Immunol. (1999)
  7. 10.1006/smim.1995.0012 / Semin. Immunol. (1995)
  8. 10.1182/blood.V97.1.192 / Blood. (2001)
  9. 10.1146/annurev.immunol.15.1.749 / Annu. Rev. Immunol. (1997)
  10. 10.1016/1074-7613(94)90087-6 / Immunity. (1994)
  11. 10.3109/10428199809050906 / Leuk. Lymphoma. (1998)
  12. 10.1084/jem.182.1.155 / J. Exp. Med. (1995)
  13. 10.1002/jlb.61.3.246 / J. Leukoc. Biol. (1997)
  14. 10.1038/376596a0 / Nature. (1995)
  15. 10.1182/blood.V93.10.3309.410k04_3309_3316 / Blood. (1999)
  16. 10.1038/83416 / Nat. Med. (2001)
  17. 10.1084/jem.193.6.661 / J. Exp. Med. (2001)
  18. 10.1016/1074-7613(95)90057-8 / Immunity. (1995)
  19. 10.1074/jbc.271.22.12687 / J. Biol. Chem. (1996)
  20. 10.1038/5517 / Nat. Med. (1999)
  21. 10.1172/JCI6926 / J. Clin. Invest. (1999)
  22. 10.4049/jimmunol.163.4.1906 / J. Immunol. (1999)
  23. 10.1073/pnas.95.13.7556 / Proc. Natl. Acad. Sci. USA. (1998)
  24. 10.1016/S0960-9822(00)00002-6 / Curr. Biol. (1994)
  25. 10.1084/jem.192.5.755 / J. Exp. Med. (2000)
  26. 10.1084/jem.191.7.1095 / J. Exp. Med. (2000)
  27. 10.4049/jimmunol.166.2.1314 / J. Immunol. (2001)
  28. 10.1084/jem.189.8.1343 / J. Exp. Med. (1999)
  29. 10.1084/jem.190.8.1155 / J. Exp. Med. (1999)
  30. 10.1084/jem.184.5.1781 / J. Exp. Med. (1996)
  31. {'key': '2023072511264624500_BIB31', 'first-page': '2770', 'volume': '59', 'year': '1999', 'journal-title': 'Cancer Res.'} / Cancer Res. (1999)
  32. {'key': '2023072511264624500_BIB32', 'first-page': '1593', 'volume': '58', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. (1998)
  33. 10.1038/ng1097-141 / Nat. Genet. (1997)
  34. 10.1126/science.281.5381.1305 / Science. (1998)
  35. 10.1016/S0960-9822(06)90000-1 / Curr. Biol. (1997)
  36. 10.1038/386517a0 / Nature. (1997)
  37. 10.1038/40657 / Nature. (1997)
  38. 10.4049/jimmunol.161.6.2833 / J. Immunol. (1998)
  39. 10.1038/35074122 / Nature. (2001)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 12:48 p.m.)
Deposited 2 years, 1 month ago (July 25, 2023, 7:28 a.m.)
Indexed 2 weeks, 6 days ago (Aug. 7, 2025, 4:57 p.m.)
Issued 23 years, 7 months ago (Jan. 14, 2002)
Published 23 years, 7 months ago (Jan. 14, 2002)
Published Online 23 years, 7 months ago (Jan. 14, 2002)
Published Print 23 years, 7 months ago (Jan. 21, 2002)
Funders 0

None

@article{Takeda_2002, title={Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development}, volume={195}, ISSN={0022-1007}, url={http://dx.doi.org/10.1084/jem.20011171}, DOI={10.1084/jem.20011171}, number={2}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Takeda, Kazuyoshi and Smyth, Mark J. and Cretney, Erika and Hayakawa, Yoshihiro and Kayagaki, Nobuhiko and Yagita, Hideo and Okumura, Ko}, year={2002}, month=jan, pages={161–169} }